These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 29949697
1. STUDYING THE PHYSICAL DEPENDENCE ON AND TOLERANCE TO THE ANTINOCICEPTIVE EFFECT OF RU-1205 SUBSTANCE. Grechko OY, Shtareva DM, Spasov AA, Litvinov LA, Rashchenko AI. Eksp Klin Farmakol; 2016 Aug; 79(4):8-11. PubMed ID: 29949697 [Abstract] [Full Text] [Related]
2. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. Bilsky EJ, Bernstein RN, Wang Z, Sadée W, Porreca F. J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958 [Abstract] [Full Text] [Related]
4. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence. Lutfy K, Parikh D, Lee DL, Liu Y, Ferrini MG, Hamid A, Friedman TC. Neuroscience; 2016 Aug 04; 329():318-25. PubMed ID: 27208618 [Abstract] [Full Text] [Related]
5. Morphine tolerance and dependence in the nociceptin receptor knockout mice. Mamiya T, Noda Y, Ren X, Nagai T, Takeshima H, Ukai M, Nabeshima T. J Neural Transm (Vienna); 2001 Aug 04; 108(12):1349-61. PubMed ID: 11810400 [Abstract] [Full Text] [Related]
6. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence. Wells JL, Bartlett JL, Ananthan S, Bilsky EJ. J Pharmacol Exp Ther; 2001 May 04; 297(2):597-605. PubMed ID: 11303048 [Abstract] [Full Text] [Related]
7. Tianeptine reduces morphine antinociceptive tolerance and physical dependence. Chu CC, Shieh JP, Shui HA, Chen JY, Hsing CH, Tzeng JI, Wang JJ, Ho ST. Behav Pharmacol; 2010 Sep 04; 21(5-6):523-9. PubMed ID: 20679893 [Abstract] [Full Text] [Related]
8. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain. Fan LW, Tanaka S, Tien LT, Ma T, Rockhold RW, Ho IK. Brain Res Bull; 2002 Jun 04; 58(2):149-60. PubMed ID: 12127012 [Abstract] [Full Text] [Related]
9. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice. Crain SM, Shen KF. Brain Res; 2007 Sep 05; 1167():31-41. PubMed ID: 17692296 [Abstract] [Full Text] [Related]
10. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis. Sinchaisuk S, Ho IK, Rockhold RW. Pharmacol Biochem Behav; 2002 Dec 05; 74(1):241-52. PubMed ID: 12376173 [Abstract] [Full Text] [Related]
11. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase. Ren X, Noda Y, Mamiya T, Nagai T, Nabeshima T. Behav Brain Res; 2004 Jul 09; 152(2):243-50. PubMed ID: 15196791 [Abstract] [Full Text] [Related]
12. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol. Fan LW, Tien LT, Tanaka S, Ma T, Chudapongse N, Sinchaisuk S, Rockhold RW, Ho IK. Neuroscience; 2003 Jul 09; 121(4):1063-74. PubMed ID: 14580956 [Abstract] [Full Text] [Related]
13. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal. Cavun S, Göktalay G, Millington WR. J Pharmacol Exp Ther; 2005 Nov 09; 315(2):949-58. PubMed ID: 16079299 [Abstract] [Full Text] [Related]
14. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol. Cichewicz DL, Welch SP. J Pharmacol Exp Ther; 2003 Jun 09; 305(3):812-7. PubMed ID: 12606610 [Abstract] [Full Text] [Related]
15. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence. Wang D, Raehal KM, Bilsky EJ, Sadée W. J Neurochem; 2001 Jun 09; 77(6):1590-600. PubMed ID: 11413242 [Abstract] [Full Text] [Related]
16. [Afobazole decreases severity of morphine withdrawal syndrome: experimental evidence]. Konstantinopol'skiĭ MA, Cherniakova IV. Eksp Klin Farmakol; 2011 Jun 09; 74(10):12-6. PubMed ID: 22238980 [Abstract] [Full Text] [Related]
17. Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence. Naidu PS, Singh A, Joshi D, Kulkarni SK. Addict Biol; 2003 Sep 09; 8(3):327-36. PubMed ID: 13129835 [Abstract] [Full Text] [Related]
18. Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine. Yano I, Takemori AE. Res Commun Chem Pathol Pharmacol; 1977 Apr 09; 16(4):721-34. PubMed ID: 16322 [Abstract] [Full Text] [Related]
19. Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine. Greenwald MK, Stitzer ML. Drug Alcohol Depend; 1998 Dec 01; 53(1):17-30. PubMed ID: 10933337 [Abstract] [Full Text] [Related]
20. Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Wang Z, Bilsky EJ, Porreca F, Sadée W. Life Sci; 1994 Dec 01; 54(20):PL339-50. PubMed ID: 7514710 [Abstract] [Full Text] [Related] Page: [Next] [New Search]